Assisted Reproduction

Assisted reproductive technologies (ARTs) are usually used to treat infertility. One of the most common technologies is in vitro fertilization (IVF), an ART procedure in which sperm and eggs are joined outside the body, and the resulting embryo is transferred to a uterus in an effort to establish a pregnancy. Surrogacy is another form of assisted reproduction that involves a woman who agrees, as a third party, to be impregnated with, gestate, and deliver the embryo of another couple or person, often in exchange for payment.

Although ARTs help some people find new avenues to have the children they’ve always wanted, they can pose significant safety risks that are often overlooked. For instance, extracting eggs from the body typically involves taking hormonal drugs to promote the simultaneous development of multiple eggs. This is true whether the eggs are for one’s own IVF treatment, for someone else’s, or to provide materials for researchers. Yet evidence about the severity and extent of risks from egg retrieval is widely recognized as inadequate. A common short-term risk is ovarian hyperstimulation syndrome (OHSS). This is often a mild reaction, but it can become serious enough to require hospitalization and, in rare cases, can cause death.

There is also strong concern about the common imbalances of power among the parties involved in assisted reproduction, particularly because policies pertaining to third-party assisted reproduction vary widely. Some jurisdictions prohibit surrogacy while others limit compensation to expenses and lost wages. In a number of U.S. states and a few other areas, surrogacy is permitted as a market transaction, often with little or no oversight. This has led some prospective parents to leave their own countries in order to avoid regulations or to save money, a phenomenon known as “cross-border reproductive care” or “reproductive tourism.” 


Aggregated News

Doctors say they’ve helped an infertile woman become pregnant by combining her egg with that of a donor—another successful use of a controversial IVF technique. 

The patient: She’s a Greek woman of 32, and four previous IVF attempts didn’t result in a pregnancy....

Biopolitical Times

Every now and then, the fertility industry claims a breakthrough. The latest is one that had little to do with how we form families—until 2016 when a fertility doctor in New York named John Zhang used it to create a baby.

Also known as nuclear genome transfer or mitochondrial replacement, three-person IVF is designed to help a tiny number of people with a specific kind of mitochondrial DNA (mtDNA) disease have healthy and genetically related children. Zhang’s work has...

Aggregated News

TORONTO — Women who become pregnant using fertility treatments — particularly in-vitro fertilization — have a slightly higher risk of...

Aggregated News

In a little over a decade, the number of foreign children adopted by Spanish parents has plunged from 5,541 to...

World map with a blue arrow indicating a market increase

Aggregated News

abstract image of circles in blue, pink, and green

Aggregated News

Biopolitical Times
Megaphone in the colors of the French flag

Aggregated News

Yellow, blue, and green flame logo over the letters OHSU (OHSU logo)

Aggregated News

Bottles of IVF hormones and a pile of syringes

Aggregated News

Photos of Stuart Newman and Tina Stevens and the cover of their book, Biotech Juggernaut

Aggregated News